This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (34)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Cardiovascular System  • Prognosis/ Outcomes  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

E. Magnus Ohman, MD; Christopher B. Granger, MD; Robert A. Harrington, MD; Kerry L. Lee, PhD

JAMA. 2000;284:876-878.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Management of acute coronary syndromes has advanced considerably during recent years, similar to the evolution in treatment of acute myocardial infarction (MI) in the 1980s. Then, fibrinolytic and aspirin therapy were shown to reduce mortality substantially.¹ Although these therapies first were applied to all patients with suspected MI,¹ those with ST-segment elevation or left bundle-branch block were shown to derive most, if not all, of the benefit.² Accelerated tissue-type plasminogen activator (tPA) then was found to be superior to streptokinase in the Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries (GUSTO-I) trial, with a relative 14% reduction in 30-day mortality.³ Mortality models suggested that tPA treatment independently predicted better outcomes, consistent across patient subgroups regardless of absolute risk.⁴ Without a heterogeneous treatment effect, the interpretation was that almost all patients with MI . . . [Full Text of this Article]

Author Affiliations: Division of Cardiology, Department of Medicine (Drs Ohman, Granger, and Harrington) and Department of Community and Family Medicine (Dr Lee), Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI: A Method for Prognostication and Therapeutic Decision Making
Elliott M. Antman, Marc Cohen, Peter J. L. M. Bernink, Carolyn H. McCabe, Thomas Horacek, Gary Papuchis, Branco Mautner, Ramon Corbalan, David Radley, and Eugene Braunwald
JAMA. 2000;284(7):835-842.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Understanding Physicians' Risk Stratification of Acute Coronary Syndromes: Insights From the Canadian ACS 2 Registry
Yan et al.
Arch Intern Med 2009;169:372-378.
ABSTRACT | FULL TEXT  

Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes
Gao et al.
Heart 2008;94:554-560.
ABSTRACT | FULL TEXT  

Postpolypectomy Colonoscopy Surveillance Guidelines: Predictive Accuracy for Advanced Adenoma at 4 Years
Laiyemo et al.
ANN INTERN MED 2008;148:419-426.
ABSTRACT | FULL TEXT  

Fasting Glucose in Acute Myocardial Infarction: Incremental value for long-term mortality and relationship with left ventricular systolic function
Aronson et al.
Diabetes Care 2007;30:960-966.
ABSTRACT | FULL TEXT  

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
Fox et al.
BMJ 2006;333:1091-1091.
ABSTRACT | FULL TEXT  

A new simplified immediate prognostic risk score for patients with acute myocardial infarction
Williams et al.
Emerg. Med. J. 2006;23:186-192.
ABSTRACT | FULL TEXT  

Value of community-derived risk models for stratifying patients with non-ST elevation acute coronary syndromes
Wong and White
Eur Heart J 2005;26:851-852.
FULL TEXT  

Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK)
Taneja et al.
Eur Heart J 2004;25:2013-2018.
ABSTRACT | FULL TEXT  

A Validated Prediction Model for All Forms of Acute Coronary Syndrome: Estimating the Risk of 6-Month Postdischarge Death in an International Registry
Eagle et al.
JAMA 2004;291:2727-2733.
ABSTRACT | FULL TEXT  

Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events
Granger et al.
Arch Intern Med 2003;163:2345-2353.
ABSTRACT | FULL TEXT  

Prognostic Value of Lead aVR in Patients With a First Non-ST-Segment Elevation Acute Myocardial Infarction
Barrabes et al.
Circulation 2003;108:814-819.
ABSTRACT | FULL TEXT  

Development of a New Head and Neck Cancer-Specific Comorbidity Index
Piccirillo et al.
Arch Otolaryngol Head Neck Surg 2002;128:1172-1179.
ABSTRACT | FULL TEXT  

Impact of a Clinical Decision Rule on Hospital Triage of Patients With Suspected Acute Cardiac Ischemia in the Emergency Department
Reilly et al.
JAMA 2002;288:342-350.
ABSTRACT | FULL TEXT  

Risk stratification and treatment benefits in patients with non-ST-elevation acute coronary syndromes
White and Wong
Eur Heart J 2002;23:187-191.
FULL TEXT